Pentwater Capital Management’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Pentwater Capital Management’s Portfolio GRCL Stock Details GRCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,461,000	Closed	-$14.7M	–	145
2023 Q4	$14.7M	Buy	+1,461,000	New	+$6.63M	0.16%	57

Pentwater Capital Management's GRCL Position: Q1 2024 in Review

Pentwater Capital Management sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q1 2024, closing a stake of 1,461,000 shares — an estimated $14.7M sold.

Pentwater Capital Management first reported a position in GRCL in Q4 2023 and held it in 1 quarter. The position peaked at $14.7M in Q4 2023. 0 funds tracked by Wall St. Rank hold GRCL as of Q1 2024.

Pentwater Capital Management reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Pentwater Capital Management sold 1,461,000 Gracell Biotechnologies Inc. American Depositary Shares shares in Q1 2024, an estimated $14.7M.
Pentwater Capital Management first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q4 2023 and held it in 1 quarter.
Pentwater Capital Management's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $14.7M in Q4 2023.
0 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q1 2024.

Based on Pentwater Capital Management's 13F filing for Q1 2024, filed 15 May 2024.